ERYTECH to Participate in Upcoming Virtual Investor Conferences in March

    NEXT STORY
    Brandywine Realty Trust Announces Common Quarterly Dividend, and Confirms First Quarter 2021 Earnings Release and Conference Call
    PREV STORY
    CytomX Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    PCI Biotech to present Phase I fimaVacc results at ESMO Immuno-Oncology 2019

    author_avatar
    NASDAQ Market News

    Corvus Pharmaceuticals Announces Results of Preclinical Studies Demonstrating Enhanced Immune Responses and Anti-Tumor Activity with CPI-444, an Investigational Immuno-Oncology Therapy

    BURLINGAME, Calif., April 19, 2016 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Zynerba Pharmaceuticals Presents Health State Utility Index Data on Severity of Fragile X Syndrome (FXS) and Diagnostic Challenges Faced by Caregivers 

    author_avatar
    NASDAQ Market News